-transparent.png){kind=logo}
The tumor promotor 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with calcium ionophores has been shown to bypass the requisite antigen- or lectin-induced signal for lymphocyte mitogenesis. This suggests that protein kinase C activation and calcium mobilization may be early events required for lymphocyte proliferation. Therefore, the relationship(s) of protein kinase C activation and calcium mobilization to ornithine decarboxylase induction and cellular proliferation were examined in a rat node lymphoma cell line (Nb2) which is dependent upon prolactin (PRL) for mitogenesis. TPA enhanced PRL-stimulated Nb2 node lymphoma cell ornithine decarboxylase induction and [3H]thymidine incorporation. Addition of a calcium ionophore (A23187) to cultures containing TPA plus PRL increased ornithine decarboxylase above PRL alone or PRL plus TPA but inhibited proliferation compared to the PRL plus TPA regimen. Exposure of cells to TPA or TPA plus A23187 increased [3H]thymidine incorporation in a similar manner to that demonstrated for low-dose PRL. However, optimal concentrations were only 20-25% as effective as mitogens as was optimal PRL. Protein kinase C and calmodulin antagonists inhibited PRL-stimulated ornithine decarboxylase induction and proliferation. Ca2+ chelation or cation channel antagonism inhibited both PRL-stimulated responses. The cyclic AMP analogue, 8Br-cAMP, inhibited PRL-stimulated ornithine decarboxylase activity as well as cellular proliferation processes assessed by [3H]thymidine incorporation. Finally, tumor-promoting phorbol esters inhibited 125I-rPRL binding. These data strongly suggest that protein kinase C activation and calcium mobilization are requisite events for PRL-stimulated ornithine decarboxylase induction and cellular proliferation in Nb2 node lymphoma cells. An additional component that is linked to alterations in K+ channeling is also implicated. These data support a role for protein kinase C in PRL-coupled mitogenesis. However, other critical Ca2+ and/or ion-induced events are also required.
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
June 1988,
Endocrinology,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
October 1986,
Biochimica et biophysica acta,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
May 1995,
Journal of cellular physiology,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
November 1989,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
May 1993,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
January 1995,
Archives of biochemistry and biophysics,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
May 1986,
Biochemistry and cell biology = Biochimie et biologie cellulaire,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
December 1993,
Molecular and cellular endocrinology,
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
March 1985,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A R Buckley, and
D W Montgomery, and
R Kibler, and
C W Putnam, and
C F Zukoski, and
P W Gout, and
C T Beer, and
D H Russell
May 1989,
Endocrinology,
